BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25742223)

  • 1. Value of FDG PET/CT in staging of oral cancer: four simultaneous primary malignancies.
    Linz C; Müller-Richter UD; Kircher S; Lapa C; Bluemel C
    Clin Nucl Med; 2015 May; 40(5):455-7. PubMed ID: 25742223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity.
    Goerres GW; Schmid DT; Grätz KW; von Schulthess GK; Eyrich GK
    Oral Oncol; 2003 Sep; 39(6):547-51. PubMed ID: 12798396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Linz C; Brands RC; Hackenberg S; Hartmann S; Iring T; Hohm J; Haug L; Kertels O; Kircher M; Dierks A; Buck AK; Brumberg J; Lapa C
    J Craniomaxillofac Surg; 2022 Aug; 50(8):671-676. PubMed ID: 35794029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical values of (18) F-FDG PET/CT in oral cavity cancer with dental artifacts on CT or MRI.
    Hong HR; Jin S; Koo HJ; Roh JL; Kim JS; Cho KJ; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2014 Nov; 110(6):696-701. PubMed ID: 24995957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx.
    Krabbe CA; Balink H; Roodenburg JL; Dol J; de Visscher JG
    Int J Oral Maxillofac Surg; 2011 Nov; 40(11):1263-70. PubMed ID: 21824748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma.
    Pentenero M; Cistaro A; Brusa M; Ferraris MM; Pezzuto C; Carnino R; Colombini E; Valentini MC; Giovanella L; Spriano G; Gandolfo S
    Head Neck; 2008 Nov; 30(11):1488-96. PubMed ID: 18767178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solitary peritoneal lymph node metastasis of head and neck cancer diagnosed with FDG-PET/CT imaging.
    Kim YW; Lee BJ; Lee JC; Jeon TY; Kim HJ
    Ear Nose Throat J; 2014 Dec; 93(12):E28-30. PubMed ID: 25531851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
    Suzuki H; Hasegawa Y; Terada A; Ogawa T; Hyodo I; Suzuki M; Nakashima T; Tamaki T; Nishio M
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1191-5. PubMed ID: 19015450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status?
    Kendi AT; Magliocca K; Corey A; Nickleach DC; Galt J; Higgins K; Beitler JJ; El-Deiry MW; Wadsworth JT; Hudgins PA; Saba NF; Schuster DM
    Clin Nucl Med; 2015 Mar; 40(3):e196-200. PubMed ID: 25608156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?
    Brouwer J; de Bree R; Comans EF; Castelijns JA; Hoekstra OS; Leemans CR
    Eur Arch Otorhinolaryngol; 2004 Oct; 261(9):479-83. PubMed ID: 14685887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between 2-(18) F-fluoro-2-deoxy-d-glucose positron emission tomography and contrast-enhanced computed tomography for measuring gross tumor volume in cats with oral squamous cell carcinoma.
    Yoshikawa H; Randall EK; Kraft SL; Larue SM
    Vet Radiol Ultrasound; 2013; 54(3):307-13. PubMed ID: 23441633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer.
    Miyazaki T; Sohda M; Higuchi T; Tanaka N; Suzuki S; Sakai M; Yokobori T; Nakajima M; Fukuchi M; Tsushima Y; Kato H; Kuwano H
    Anticancer Res; 2014 Jan; 34(1):283-7. PubMed ID: 24403475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG PET/CT for Management and Assessing Outcomes of Squamous Cell Cancer of the Oral Cavity.
    Pasha MA; Marcus C; Fakhry C; Kang H; Kiess AP; Subramaniam RM
    AJR Am J Roentgenol; 2015 Aug; 205(2):W150-61. PubMed ID: 26001119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative evaluation of patients with squamous cell carcinoma of the oral cavity: fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography and ultrasonography versus histopathology.
    Sugawara C; Takahashi A; Kubo M; Otsuka H; Ishimaru N; Miyamoto Y; Honda E
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Oct; 114(4):516-25. PubMed ID: 22986248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI.
    Stuckensen T; Kovács AF; Adams S; Baum RP
    J Craniomaxillofac Surg; 2000 Dec; 28(6):319-24. PubMed ID: 11465137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
    Roh JL; Ryu CH; Kim JS; Lee JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Sep; 43(8):757-63. PubMed ID: 17112773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.
    Haerle SK; Strobel K; Hany TF; Sidler D; Stoeckli SJ
    Head Neck; 2010 Mar; 32(3):319-25. PubMed ID: 19626642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.